Peripheral T cell lymphoma: New model + new insight

Journal of Experimental Medicine

Volumn 207, Issue 5, 2010, Pages 911-913

  Mulloy, James C ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE SYK;

CHROMOSOME TRANSLOCATION; FUSION GENE; HEMATOLOGIC MALIGNANCY; HUMAN; ITK SYK FUSION GENE; NONHUMAN; NOTE; ONCOGENE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; DISEASE MODELS, ANIMAL; HEMATOLOGIC NEOPLASMS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, T-CELL, PERIPHERAL; MICE; ONCOGENES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSLOCATION, GENETIC;

EID: 77952302298     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100608     Document Type: Note

References (20)

1. Cammenga, J. 2005. Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML. Leukemia. 19:1719-1728. doi:10.1038/sj.leu. 2403894
2. Chu, D.H., C.T. Morita, and A. Weiss. 1998. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 165:167-180. doi:10.1111/j.1600-065X.1998.tb01238.x
3. Cotta, C.V., and E.D. Hsi. 2008. Pathobiology of mature T-cell lymphomas. Clin. Lymphoma Myeloma. 8:S168-S179. doi:10.3816/CLM.2008.s.013
4. Davis, R.E., V.N. Ngo, G. Lenz, P. Tolar, R.M. Young, P.B. Romesser, H. Kohlhammer, L. Lamy, H. Zhao, Y. Yang, et al. 2010. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463:88-92. doi:10.1038/nature08638
5. de Leval, L., B. Bisig, C. Thielen, J. Boniver, and P. Gaulard. 2009. Molecular classification of T-cell lymphomas. Crit. Rev. Oncol. Hematol. 72: 125-143. doi:10.1016/j.critrevonc.2009.01.002
6. Fathi, A.T., S. Grant, and J.E. Karp. 2010. Exploiting cellular pathways to develop new treatment strategies for AML. Cancer Treat. Rev. 36:142-150. doi:10.1016/j.ctrv.2009.12.004
7. Feldman, A.L., D.X. Sun, M.E. Law, A.J. Novak, A.D. Attygalle, E.C. Thorland, S.R. Fink, J.A. Vrana, B.L. Caron, W.G. Morice, et al. 2008. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia. 22:1139-1143. doi:10.1038/leu.2008.77
8. Friedberg, J.W., J. Sharman, J. Sweetenham, P.B. Johnston, J.M. Vose, A. Lacasce, J. Schaefer-Cutillo, S. De Vos, R. Sinha, J.P. Leonard, et al. 2010. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 115:2578-2585. doi:10.1182/blood-2009-08-236471
9. Hahn, C.K., J.E. Berchuck, K.N. Ross, R.M. Kakoza, K. Clauser, A.C. Schinzel, L. Ross, I. Galinsky, T.N. Davis, S.J. Silver, et al. 2009. Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell. 16:281-294. doi:10.1016/j.ccr.2009.08.018
10. Joseph, R.E., and A.H. Andreotti. 2009. Conformational snapshots of Tec kinases during signaling. Immunol. Rev. 228:74-92. doi:10.1111/j.1600-065X.2008. 00740.x
11. Küppers, R. 2005. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer. 5:251-262. doi:10.1038/nrc1589
12. Palacios, E.H., and A. Weiss. 2007. Distinct roles for Syk and ZAP-70 during early thymocyte development. J. Exp. Med. 204:1703-1715. doi:10.1084/jem.20070405
13. Pechloff, K., J. Holch, U. Ferch, M. Schweneker, K. Brunner, M. Kremmer, T. Sparwasser, L. Quintanilla-Martinez, U. Zimber-Strobl, B. Streubel, A. Gewies, C. Peschel, and J. Ruland. 2010. The fusion kinase ITKSYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J. Exp. Med. 207:1031-1044.
14. Piccaluga, P.P., C. Agostinelli, A. Califano, M. Rossi, K. Basso, S. Zupo, P. Went, U. Klein, P.L. Zinzani, M. Baccarani, et al. 2007. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J. Clin. Invest. 117:823-834. doi:10.1172/JCI26833
15. Prince, A.L., C.C. Yin, M.E. Enos, M. Felices, and L.J. Berg. 2009. The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development. Immunol. Rev. 228:115-131. doi:10.1111/j.1600-065X.2008.00746.x
16. Rodríguez, J., A. Gutiérrez, B. Martínez-Delgado, and G. Perez-Manga. 2009. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Crit. Rev. Oncol. Hematol. 71:181-198. doi:10.1016/j.critrevonc.2008. 10.011
17. Streubel, B., U. Vinatzer, M. Willheim, M. Raderer, and A. Chott. 2006. Novel t(5;9) (q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 20:313-318. doi:10.1038/sj.leu.2404045
18. Tarantul, V.Z. 2004. Transgenic mice as an in vivo model of lymphomagenesis. Int. Rev. Cytol. 236:123-180. doi:10.1016/S0074-7696(04)36004-3
19. Tsang, E., A.M. Giannetti, D. Shaw, M. Dinh, J.K. Tse, S. Gandhi, H. Ho, S. Wang, E. Papp, and J.M. Bradshaw. 2008. Molecular mechanism of the Syk activation switch. J. Biol. Chem. 283:32650-32659. doi:10.1074/jbc.M806340200
20. Turner, M., E. Schweighoffer, F. Colucci, J.P. Di Santo, and V.L. Tybulewicz. 2000. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today. 21:148-154. doi:10.1016/S0167-5699(99)01574-1